To verify the functional effects of the NANOG-TRPV1-pEGFR axis in diverse types of cancer which cisplatin was used as the major chemotherapeutic agent, we focused on lung and gastric cancer among the various cancer types. Here, TRPV1 is linked to gastric cancer.